Drugs / Bioferon
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07634094 | Aug 2026 → Aug 2028 expected | ovarian cancer | Kalinski, Pawel, MD, PhD | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bioferon | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07634094 ↗ |
| Route | Other | “IP over 30-60 minutes” NCT07634094 ↗ |